{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:40:33Z","timestamp":1790304033127,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,3,1]],"date-time":"2004-03-01T00:00:00Z","timestamp":1078099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1016\/j.toxicon.2003.11.024","type":"journal-article","created":{"date-parts":[[2004,1,17]],"date-time":"2004-01-17T10:15:16Z","timestamp":1074334516000},"page":"233-241","source":"Crossref","is-referenced-by-count":23,"title":["Engineering of a recombinant Fab from a neutralizing IgG directed against scorpion neurotoxin AahI, and functional evaluation versus other antibody fragments"],"prefix":"10.1016","volume":"43","author":[{"given":"Nicolas","family":"Aubrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Muzard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Christophe Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Rochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Goyffon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Devaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Billiald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2003.11.024_BIB1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(98)12083-4","article-title":"Serotherapy in scorpion envenomation: a randomised controlled trial","volume":"354","author":"Abroug","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0022-1759(00)00221-0","article-title":"Methods for the generation of chiken monoclonal antibody fragments by phage display","volume":"242","author":"Andris-Widhopf","year":"2000","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB3","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1515\/BC.2001.197","article-title":"A recombinant scFv\/streptavidin-binding peptide fusion protein for the quantitative determination of the scorpion venom neurotoxin AahI","volume":"382","author":"Aubrey","year":"2001","journal-title":"Biol. Chem."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s000180300053","article-title":"Design and evaluation of a diabody to improve protection against a potent scorpion neurotoxin","volume":"60","author":"Aubrey","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB5","doi-asserted-by":"crossref","first-page":"10701","DOI":"10.1073\/pnas.170297297","article-title":"Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity","volume":"97","author":"Boder","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0196-0644(05)81022-4","article-title":"Antivenin administration for centruroides scorpion sting\u2014risks and benefits","volume":"21","author":"Bond","year":"1992","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/11717","article-title":"Therapeutic antibody fragments with prolonged in vivo half-lives","volume":"17","author":"Chapman","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB8","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0041-0101(97)00160-8","article-title":"Venoms, antivenoms and immunotherapy","volume":"36","author":"Chippaux","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0014-5793(99)01179-5","article-title":"Monoclonal antibodies against the Androctonus australis hector scorpion neurotoxin I: characterisation and use for venom neutralisation","volume":"458","author":"Clot-Faybesse","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1385\/MB:21:1:057","article-title":"Validation of biopharmaceutical purification processes for virus clearance and evaluation","volume":"21","author":"Darling","year":"2002","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0014-5793(97)00826-0","article-title":"Monoclonal antibodies neutralizing the toxin II from Androctonus australis hector scorpion venom: usefulness of a synthetic, non-toxic analog","volume":"412","author":"Devaux","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB12","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1046\/j.1432-1327.2001.01923.x","article-title":"Construction and functional evaluation of a single-chain antibody fragment that neutralizes toxin AahI from the venom of the scorpion Androctonus australis hector","volume":"268","author":"Devaux","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB13","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0041-0101(02)00178-2","article-title":"Intraspecific variability and pharmacokinetic characteristics of Androctonus mauretanicus mauretanicus scorpion venom","volume":"40","author":"El Hafny","year":"2002","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/106002809603000309","article-title":"ABCIXIMAB: a new antiaggregant used in angioplasty","volume":"30","author":"Genetta","year":"1996","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0167-5699(00)01669-8","article-title":"Clinical trials of antibody therapy","volume":"21","author":"Glennie","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/protein\/gzg042","article-title":"VL position 34 is a key determinant for the engineering of stable antibodies with fast dissociation rates","volume":"16","author":"Hugo","year":"2003","journal-title":"Protein Engng"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB17","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/HAB-2001-103-405","article-title":"Engineered antibodies take center stage","volume":"10","author":"Huston","year":"2001","journal-title":"Hum. Antibodies"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB18","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0041-0101(98)00144-5","article-title":"Pharmacokinetic of 125I-labelled IgG, F(ab)\u20322 and Fab fractions of scorpion and snake antivenins: merits and potential for therapeutic use","volume":"36","author":"Ismail","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB19","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0041-0101(99)00079-3","article-title":"Evaluation of antivenom therapy in children severely envenomed by Androctonus australis garzonii (Aag) and Buthus occitanus tunetanus (Bot) scorpions","volume":"37","author":"Krifi","year":"1999","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0167-5699(00)01668-6","article-title":"Of mice and men: hybridoma and recombinant antibodies","volume":"21","author":"Little","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB21","series-title":"Handbook of Neurotoxicity","first-page":"683","article-title":"Scorpion neurotoxins: effects and mechanisms","author":"Martin-Eauclaire","year":"1995"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt0602-597","article-title":"Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity","volume":"20","author":"Maynard","year":"2002","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB23","doi-asserted-by":"crossref","first-page":"23775","DOI":"10.1074\/jbc.272.38.23775","article-title":"The functional architecture of an acetylcholine receptor-mimicking antibody","volume":"272","author":"Merienne","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB24","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0014-5793(98)01647-0","article-title":"A recombinant single-chain antibody fragment that neutralizes toxin II from the venom of the scorpion Androctonus australis hector","volume":"442","author":"Mousli","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB25","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0022-1759(80)90107-6","article-title":"Calculation of average antibody affinity in anti-hapten sera from data obtained by competitive radioimmunoassay","volume":"34","author":"Muller","year":"1980","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB26","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody","volume":"99","author":"Nowakowski","year":"2002","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB27","doi-asserted-by":"crossref","first-page":"36740","DOI":"10.1074\/jbc.M306877200","article-title":"scFv single chain antibody variable fragment as inverse agonist of the b2-adrenergic receptor","volume":"278","author":"Peter","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(05)72007-9","article-title":"Antivenom for scorpion sting","volume":"355","author":"Possani","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1128\/mr.57.1.50-108.1993","article-title":"The complete general secretory pathway in gram-negative bacteria","volume":"57","author":"Pugsley","year":"1993","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB30","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-2836(02)00023-2","article-title":"Knowledge-based design of reagentless fluorescent biosensors from recombinant antibodies","volume":"318","author":"Renard","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB31","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/abio.1997.2183","article-title":"Concentration measurement of unpurified proteins using biosensor technology under conditions of partial mass transport limitation","volume":"249","author":"Richalet-Secordel","year":"1997","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB32","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0003-2697(77)90192-0","article-title":"Radioiodination of scorpion and snake toxins","volume":"82","author":"Rochat","year":"1977","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB33","series-title":"Molecular Cloning. A laboratory manual","author":"Sambrook","year":"1989"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s000180300037","article-title":"Molecular farming of recombinant antibodies in plants","volume":"60","author":"Schillberg","year":"2003","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB35","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0022-3476(05)83196-8","article-title":"Scorpion envenomation and antivenom therapy","volume":"124","author":"Sofer","year":"1994","journal-title":"J. Pediatr."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB36","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.4049\/jimmunol.169.2.1119","article-title":"Superhumanized antibodies: reduction of immunogenic potential by complementary-determining region grafting with human germline sequences: application to an anti-CD28","volume":"169","author":"Tan","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0041-0101(02)00393-8","article-title":"Report of a WHO workshop on the standardization and control of antivenoms","volume":"41","author":"Theakston","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2003.11.024_BIB38","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0168-1656(99)00037-1","article-title":"A recombinant Fab neutralizes dengue virus in vitro","volume":"69","author":"Thullier","year":"1999","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.toxicon.2003.11.024_BIB39","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1006\/jmbi.2000.4265","article-title":"Stability engineering of antibody single-chain Fv fragments","volume":"305","author":"Worn","year":"2001","journal-title":"J. Mol. Biol."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010103003647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010103003647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T01:05:14Z","timestamp":1623632714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010103003647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,3]]}},"alternative-id":["S0041010103003647"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2003.11.024","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}